Veru VERU
NASDAQ VERU
$2.66 +0.08 (+3.10%)
As of: Aug 21, 2026 · 1:17 PM EDT

Veru (VERU) Dividends payables (2011 - 2013)

Veru (VERU) posted quarterly Dividends payables of $8170.0 for Q2 2013, down 43.34% year-over-year from $14420.0 in Q2 2012, and down 99.6% quarter-over-quarter from $2.0 million in Q1 2013.

Veru (VERU) Dividends payables (2011 - 2013) Analysis & Trends

Veru (VERU) has reported Dividends payables for 3 consecutive years, with $8170.0 the latest figure, recorded in Q2 2013.

  • In Q2 2013, Dividends payables fell 43.34% year-over-year to $8170.0; the TTM figure through Jun 2013 stood at $8170.0 (down 43.34% YoY), while the FY2012 annual figure was $24570.0, up 19.27% from the prior year.
  • Dividends payables slipped to $8170.0 in Q2 2013 per VERU's latest filing, from $2.0 million in the prior quarter.
  • Across five years, Dividends payables topped out at $2.0 million in Q1 2013 and bottomed at $8170.0 in Q2 2013.
  • Historically, Dividends payables has averaged $866055.5 across 3 years, with a median of $717399.5 in 2011.
  • Annual changes were most pronounced in 2012 — Dividends payables increased 22.94% — and 2013, when it sank 43.34%.
  • Veru's Dividends payables stood at $1.4 million in 2011, then increased by 22.94% to $1.7 million in 2012, then sank by 99.53% to $8170.0 in 2013.
  • Business Quant data shows VERU's Dividends payables at $8170.0 in Q2 2013, $2.0 million in Q1 2013, and $1.7 million in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Vertex Pharmaceuticals 139.29 Bn 131.44 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.31 Bn 78.32 Bn 3.93 Bn -
3 Argenx Se 65.22 Bn 60.03 Bn 1.37 Bn -
4 Moderna 58.92 Bn 53.78 Bn 52.00 Mn -
5 BeOne Medicines 42.07 Bn 36.97 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.70 Bn 28.39 Bn 992.69 Mn -
7 BioNTech SE 27.99 Bn 9.60 Bn 668.28 Mn -
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn -
9 Royalty Pharma 27.28 Bn 26.45 Bn - -
10 Veru 61.31 Mn 35.52 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2013 8,170.00
Mar 31, 2013 2.02 Mn
Dec 31, 2012 1.73 Mn
Sep 30, 2012 24,570.00
Jun 30, 2012 14,420.00
Mar 31, 2012 1.70 Mn
Dec 31, 2011 1.41 Mn
Sep 30, 2011 20,600.00